CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹11 Cr | ₹-14 Cr | ₹12 Cr | ₹2.83 Cr | ₹-4.48 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CONCORD BIOTECH ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹11 Cr |
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹2.83 Cr |
| Mar2022 | ₹-4.48 Cr |
How is Net Cash Inflow / Outflow of CONCORD BIOTECH Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹11 Cr | Positive | |
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹12 Cr | 311.12 | |
| Mar2023 | ₹2.83 Cr | Positive | |
| Mar2022 | ₹-4.48 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹16,121.0 Cr | -1.6% | 23.4% | -3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -1.6% |
23.4% |
-3.9% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses